206 related articles for article (PubMed ID: 15709889)
1. Modafinil: new indications for wake promotion.
Schwartz JR
Expert Opin Pharmacother; 2005 Jan; 6(1):115-29. PubMed ID: 15709889
[TBL] [Abstract][Full Text] [Related]
2. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
Keating GM; Raffin MJ
CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
[TBL] [Abstract][Full Text] [Related]
3. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
Black JE; Hirshkowitz M
Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
[TBL] [Abstract][Full Text] [Related]
4. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Black J; Houghton WC
Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the safety of modafinil for treatment of excessive sleepiness.
Roth T; Schwartz JR; Hirshkowitz M; Erman MK; Dayno JM; Arora S
J Clin Sleep Med; 2007 Oct; 3(6):595-602. PubMed ID: 17993041
[TBL] [Abstract][Full Text] [Related]
6. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
[TBL] [Abstract][Full Text] [Related]
7. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
[TBL] [Abstract][Full Text] [Related]
8. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
Hirshkowitz M; Black J
CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
[TBL] [Abstract][Full Text] [Related]
9. Modafinil/armodafinil in obstructive sleep apnoea: a systematic review and meta-analysis.
Chapman JL; Vakulin A; Hedner J; Yee BJ; Marshall NS
Eur Respir J; 2016 May; 47(5):1420-8. PubMed ID: 26846828
[TBL] [Abstract][Full Text] [Related]
10. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
[TBL] [Abstract][Full Text] [Related]
11. Armodafinil.
Garnock-Jones KP; Dhillon S; Scott LJ
CNS Drugs; 2009 Sep; 23(9):793-803. PubMed ID: 19689169
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
[TBL] [Abstract][Full Text] [Related]
13. Armodafinil: a new treatment for excessive sleepiness.
Lankford DA
Expert Opin Investig Drugs; 2008 Apr; 17(4):565-73. PubMed ID: 18363520
[TBL] [Abstract][Full Text] [Related]
14. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
Sukhal S; Khalid M; Tulaimat A
J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
[TBL] [Abstract][Full Text] [Related]
15. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
Inoue Y; Miki M; Tabata T
Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
[TBL] [Abstract][Full Text] [Related]
16. Modafinil: new indication. For a minority of patients with sleep apnoea.
Prescrire Int; 2007 Jun; 16(89):102-3. PubMed ID: 17582924
[TBL] [Abstract][Full Text] [Related]
17. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
[TBL] [Abstract][Full Text] [Related]
18. Armodafinil for excessive daytime sleepiness.
Nishino S; Okuro M
Drugs Today (Barc); 2008 Jun; 44(6):395-414. PubMed ID: 18596995
[TBL] [Abstract][Full Text] [Related]
19. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
[TBL] [Abstract][Full Text] [Related]
20. Modafinil in the treatment of idiopathic hypersomnia without long sleep time--a randomized, double-blind, placebo-controlled study.
Mayer G; Benes H; Young P; Bitterlich M; Rodenbeck A
J Sleep Res; 2015 Feb; 24(1):74-81. PubMed ID: 25196321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
